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While much research has examined factors thought to 
affect patient compliance with therapeutic regimen, rela-
tively little is known about the relationship between 
psychiatric patients' attitudes toward treatment regimen 
and their adherence to the treatment regimen. Compliance 
rates for psychiatric patients remain the lowest of the 
medical patient population, probably due to psychological 
and social characteristics of psychiatric patients. Be-
cause of a trend in the United States toward self-medication 
·-........ for an increasingly ambulatory psychiatric patient popula-
tion, the ability to predict patient compliance with 
medication regimen has become more important than ever be-
fore. Before potential noncompliers can be identified and 
patient compliance predicted through the use of attitudes, 
an examination of the nature of these attitudes is needed. 
Scientific literature and theory suggest that attitude 
is one of several variables which corresponds to behavior. 
Specific attitudes are thought to develop as a result of 
2 
real or vicarious experience with the attitude referent. In 
addition, research has shown that attitudes toward specific 
objects correlate highly with beliefs, behavioral intentions, 
and behavior. Therefore, it is hypothesized that psychiatric 
patients with prior medicine-taking experience will have de-
veloped different patterns of attitudes toward pharmacologi~ 
cal treatment than will medicine-naive patients. The hypo-
thesis implies that knowing these attitudes will permit pre-
diction of compliance of experienced and naive patients with 
therapeutic regimen. 
As the first step of investigating using attitudes to 
predict compliance, a 20-item Likert-type rating scale, the 
Psychiatric Medicine Attitude Scale (PMAS), was developed. 
An alternate forms reliability coefficient of .93 was ob-
tained. Mean score for Form A for the psychiatric medicine-
experienced subjects was 2.85, for the medicine-naive sub-
jects, 3.40. Form B scores were 3.17 for the experienced 
subjects and 3.51 for the naive subjects. These scores show 
that on both Forms A and B, individuals without prior experi-
ence with psychiatric medicine tended tb express more neg-
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ative attitudes toward the referent object than did the sub-
jects who had previous medicine experience. 
The next steps, outside the range of this project, will 
be to develop norms and to ascertain if compliance behaviors 
will be a function of PMAS scores. 
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CHAPTER I 
INTRODUCTION 
One of the most valuable contributions clinical re-
search can make to the practice of mental health care is to 
strengthen the clinician's ability to predict treatment re-
sponse. It is generally recognized that psycholog1cal char-
acteristics of patients play a significant role in deter-
mining treatment outcome. Particularly worthy of clinical 
study are those psychological variables which influence com-
pliance with or adherence to treatment regimen. 
Research results provide evidence which indicates that 
a patient's beliefs and feelings influence his or her treat-
ment adherence, and that by studying the patient's attitudes 
toward following treatment regimen, rather than the patient's 
personality, compliance can be predicted (Rosenstock, 1974; 
Valins & Nisbett, 1971). 
As an exploratory study, the major tasks of this project 
are threefold: to review the ~linical history of compliance, 
to summarize the theoretical issues regarding the relation-
ship between the patient's attitudes and treatment adherence, 
and to develop a practical and reliable test to measure a 
patient's attitude toward taking psychiatric medicine. 
Clinical History of Compliance 
Clinicians find the ability to identify potentially 
noncompliant patients vital where pharmacological adherence 
often means the difference between outpatient and inpatient 
status. Early identification of potential noncompliers 
increases treatment efficiency by reducing the number and 
extent of drug trials, conserving medical resources, and 
encouraging· greater involvement of the patient in the 
treatment regimen. Health educators note that greater 
patient involvement in treatment results in more rapid 
recovery (Barsky, 1976; Mathews, 1976). 
Three major reviews chronicle the increasing interest 
in the compliance problem first detailed by Bergman and 
Werner (1963) and later by Porter (1969). In their book 
written for the "1974 Workshop/Symposium on Compliance with 
Therapeutic Regimens," Sac.kett and Haynes (1976) prepared 
an annotated bibliography of 246 articles published 
by 1973. Pothier (1975) compiled a bibliography of 
74 references on compliance from.the National Library 
of Medicine. And, most pertinent to this study, using 
the above studies and an earlier review of his own, 
Blackwell (1976) extracted and examined 55 articles which 
concerned compliance with medication regimens of psychi-
atric patients. 
2 
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Magnitude of Compliance and Noncompliance 
Compliance is defined generally as, "the extent to 
which the patient's behavior (in terms of taking medica-
tions, following diets, or executing other life-style 
changes) coincides with the clinical prescription" (Sackett 
& Haynes, 1976, p. 1). Compliance with medication regimens 
is usually measured in terms of rate of omission, some 
range of medicine-taking defined "compliant" by the in-
vestigators, for example, 80% to 120% of prescribed daily 
dosage. Blackwell (1976) found the rate of complete omis-
sion (taking no medication at all) among psychiatric out-
patients to vary from 25% to 50%. Compliance as measured 
by pill count for neurotic outpatients on randomized medi-
cation trials was reported to range from 23% to 54%; the 
former percentage when compliance was defined as taking 
all the prescribed medicine, the latter when compliance 
was defined as intake within 25% of the prescribed amount 
(Lipman, Rickels, Uhlenhuth, Park, & Fisher, 1965; Rickels 
& Briscoe, 1970). A study of psychiatric outpatients 
taking phenothiazines yielded a compliance rate, measured 
by urine assay, of 65% (Irwin, Weitzel!, & Morgan, 1971). 
These studies reveal that clinicians should expect their 
psychiatric outpatients to comply with medication regimen 
alone, from between 23% to 75% of the time. 
Distribution patterns might be as important as 
adherence rates in determining compliance. A study by 
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Gordis, Markowitz, and Lilienfeld (1969) shows a U-shaped 
distribution of compliance behavior. They found that one-
third of the patients were totally noncompliant, one-third 
took almost all medication prescribed, and the remaining 
third were scattered in between. The practical implica-
tions of a U-shaped distribution pattern of compliance are 
different than those implied by consideration of a statisti-
cally normal distribution curve. To thoroughly evaluate 
the magnitude of the compliance problem, continued research 
on distribution pattern as well as average rates is needed. 
Determinants of Compliance 
A review of factors thought to influence compliance 
supports Porter (1969) in his conclusion that "every patient 
is a potential defaulter" (p. 222). While this comment 
may appear cynical, contrary to popular wisdom most helping 
professionals generally err in predicting their patients' 
treatment adherence. In the 1976 review by Sackett and 
Haynes, none of the five articles reporting research on 
the ability of the therapist to predict patient adherence 
found any association between therapist predi~tions and 
actual patient compliance. Other researchers have corrob-
orated and updated these results with the finding that 
physicians' accuracy in predicting patient compliance did 
not improve as familiarity with the patient increased 
(Roth & Caron, 1978; Roth, Caron, & Hsi, 1971). Neverthe-
less, certain determinants appear regularly in the 
scientific literature on compliance. These variables in-
clude certain patient factors, features of the illness, 
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the patient-therapist relationship, features of the medica-
tion regimen, and the treatment setting. 
Patient factors. When correlating demographic fac-
tors with keeping scheduled appointment for mixed diagnoses 
patient samples, most reports in the Sackett and Haynes 
(1976) review found no link between sex, age, education, 
marital status, race, nor religion and the compliant behav-
ior. When examining the data for medication adherence 
alone, Blackwell (1976) found no patient fac.tors which 
consistently decreased adherence to medieal regimens. He 
did, however, discover four factors which tended to in-
crease treatment compliance: (a) considering the disease 
a serious one, (b) family stability, (c) compliance with 
other aspects of treatment, and (d) patient satisfaction 
with treatment. The family stability factor is related 
to the variable of supervision by spouse or partner, a 
factor which dramatically increases medication adherence 
(Parkes, Brown, & Monck, 1962; Porter, 1969; Renton, 
Affleck, Carstairs, & Forrest, 1963; Willcox, Gil~n, & 
Hare, 196"5). That psychiatric patients, often: social1y with-
drawn, are least compliant of the medical patient popula-
tion is not surprising in light of these findings. 
Features of the illness. Within the general medical 
patient population, few significant correlations are 
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observed between treatment compliance and features of the 
disease such as severity, duration, previous bouts, recency 
of last attack, previous hospitalizations, degree of dis-
ability, and symptoms. By isolating psychiatric diagnoses 
in terms of disease severity, duration, and consequences 
of ceasing medicine, however, identification of noncompliers 
becomes more possible. In general, psychiatric patients, 
especia1ly schizophrenics with paranoid features and 
patients with personality disorders, are significantly 
less compliant than patients with an organic diagnosis 
(Sackett & Haynes, 1976; Wilson & Enoch, 1967). For 
psychiatric patients, other investigators found that 
adherence worsens as the severity of diagnosis increases, 
suggesting that the ability to cooperate is impaired among 
the chronic, more disabled patients (Blackwell, 1976). 
Nonadherence was highest in schizophrenics most ill at 
time of discharge, for example. The same researchers found 
that those patients with less severe diagnoses attended 
outpatient clinics and adhered to medication more faith-
fully (Renton et al., 1963). Among neurotics, the most 
anxious outpatients with poorest prognoses and histories 
of prior treatment elsewhere had lowest adherence (Lipman 
et al., 1965). 
Besides disease severity, the consequences of stopping 
medicine are related to noncompliance among psychiatric 
patients. For example, when patients with diagnoses of 
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manic-depressive illness or schizophrenia interrupt their 
medication regimen, their symptoms do not reappear imme-
diately upon cessation of medicine. Therefore, the con-
sequences of these patients' noncompliance are delayed. 
Without experiencing an immediate negative consequence, 
conditions are established which support defaulting rather 
than medicine-taking. As Blackwell (1973) notes, patients 
adhere to medication therapies more carefully when relapse 
is severe or immediate, and tend to be less compliant as 
the duration of remission increases. 
Patient-therapist relationship. Because research 
has shown patient compliance to be higher in private prac-
tice than in clinics, the relationship between patient and 
therapist is important in the study of compliance (Blackwell, 
1972). Although this variable is complex and obviously 
intercorrelated with the continuity of care topic, certain 
relevant findings have emerged from the study of the 
general medical patient population. 
Sackett and Haynes (1976) report that the patient's 
general satisfaction with the therapist and the clinic, 
and his or her conclusion that the therapist had met the 
patient's expectations, both correlate positively with 
treatment compliance. The specific elements to which 
patients attend when rating satisfaction or dissatisfaction 
with their therapist have received little evaluation in 
scientific literature, however. To date, satisfaction in 
8 
the patient-therapist relationship has been approached from 
study of contributing environmental characteristics and 
therapist attitudes primarily. Studies have shown that 
more positive therapist attitudes toward the patient and 
toward the role of medicine in treatment, as shown by more 
positive affective responses, more optimistic treatment 
prognoses, and a belief in medication as essential, tend 
to increase patient adherence (Irwin et al., 1971; Shapiro, 
1974). An earlier report revealed that therapists with the 
most compliant patients were more reassuring about side 
effects and expected gains (Reynolds, Joyce, Swift, Tooley, 
& Weatherall, 1965). Adherence with regimen also declined 
when a second physician was substituted for the regular 
caretaker (Becker, Drachman, & Kirscht, 1972). Again, the 
above investigations have used general medical populations; 
unfortunately little research has been published on the 
therapist-patient relationship as it relates to compliance 
within a psychiatric population. 
Features of the medication regimen. Research on 
general medical patients has shown consistently that com-
pliance is adversely affected when drugs are given in 
frequent, divided doses, and when multiple medications are 
prescribed. In addition, side effects correlate with dis-
continuing medication, as might be expected (Porter, 1969; 
Renton et al., 1963). Different compliance rates have 
been found for alternative drugs and alternate methods of 
administration, but as Sacket and Haynes (1976) note, 
these findings are inconsistent. 
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The degree of behavior change required also correlates 
with adherence. Sackett and Haynes (1976) found a relation-
ship where least behavior change required by the treatment 
regimen relates to highest regimen compliance, and high 
required behavior change correlates with lower compliance. 
It appears that compliance worsens as new medicine taking 
behavior is required, decreases further if changing old 
behavior is necessary, and is lowest when breaking personal 
habits such as smoking or drinking becomes necessary for 
regimen compliance. This pattern may explain the findings 
noted earlier of decreased adherence with increasingly 
complex regimens. 
Treatment milieu. In general medicine, adherence 
can be increased by managing environmental variables such 
as patient waiting time in the clinic or office, increasing 
convenience of clinic and pharmacy, and by simplifying 
intake and scheduling procedures (Irwin et al., 1971; 
Raynes & Warren, 1971). Few studies are available on the 
effect of the treatment setting on compliance for the 
psychiatric patient. We can assume that factors which 
exacerbate continuity of patient care and minimize the 
degree of supervision and support can only have a negative 
effect upon the patient whose illness reduces his or her 
awareness of treatment efforts in the first place. 
CHAPTER II 
STATEMENT OF THE CLINICAL PROBLEM 
The problem of compliance with therapeutic regimen 
continues to challenge health care professionals. With 
increasing use of oral medications, more responsibility for 
self-medication is shifting to the patient at a time when 
few factors are known to predict clearly compliance behavior. 
Research has shown that less disabled psychiatric patients 
with more intact social support systems, enduring relation-
ships with caring health professionals, and simple medica-
tion schedules, adhere to treatment plans more consistently 
than the more disturbed patients who have less social sup-
port, less familiar physicians, and more complicated treat-
ment regimens. 
Researchers see hope that patient education can 
increase compliance but results to date are contradictory. 
In certain cases, medicine compliance increases with more 
knowledge and instruction, but other reports show the 
most knowledgeable general medical patients to be the most 
flagrant noncompliers (Carpenter & Davis, 1976). 
The Health Beliefs Model (HBM) suggests that a 
patient's motivation to take preventative health action 
affects compliance with treatment. According to this 
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model, factors defining a readiness to act include the 
patient's perceived susceptibility to the disease, his or 
her perception of disease severity, the patient's judgment 
of treatment feasibility and efficacy, and attention to 
internal and external cues to action (Rosenstock, 1966). 
Experimental evaluation of the HBM has yielded inconsistent 
results. Perceived severity of the disease enhanced 
adherence in cystic fibrosis patients (Meyers, Dolan, & 
Mueller, 1975). In hypertensive patients, however, only 
the perception of the social consequences of being ill 
predicted compliance (Taylor, cited in Sackett, 1978). 
Blackwell (1976) suggests that educational strategies like 
the HBM err in their emphasis on fear as a motivator; he 
describes the paradoxical effects which result when some 
patients are urged by threat of debilitation to comply with 
treatment. Like the alcoholic driven to drink out of fear 
of cirrhosis, the noncompliant patient avoids anxiety by 
forgetting his or her medication, a reminder of sickness. 
Further contradiction of the assumption that people are 
motivated by the negative valence of disease is the 
evidence that illness seems to fulfill an important 
function in some lives. Examples of patients refusing help 
abound in clinical literature. See the Simonton's work 
with cancer patients, Ellerbroek's treatment of acne 
vulgaris patients, the apparent preference for a grandiose 
psychosis among some noncompliant schizophrenics, and 
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Minuchin's studies of psychosomatic families (VanPutten, 
Crumpton, & Yale, 1976; Ellerbroek, 1978; Minuchin, Rosman, 
& Baker, 1978; Simonton & Simonton, 1975). 
In those cases where improving compliance is truly 
beneficial, where as Sackett (1978) states, treatment is 
known to do more good than harm, where low compliance is a 
documented problem, and where low compliance interferes 
with treatment goals, a test inquiring about patient 
attitudes toward treatment has much practical value. A 
recent study by Sackett (1977) supports identifying 
patients' attitudes. Sackett learned that hypertensive 
patients who admitted noncompliance improved significantly 
when offered help with medicine-taking strategy. Those who 
verified their compliance but who were, in fact, not 
complying, did not improve. It is suggested that surveying 
attitudes can predict patient compliance with medication 
regimen. 
It is proposed that a Psychiatric Medicine Attitude 
Scale (PMAS), constructed to measure a patient's attitude 
toward using psychiatric medicines, will be useful in 
screening for potential noncompliers among a psychiatric 
patient population. If an attitude-compliance relationship 
can be determined, the PMAS will provide an objective index 
to compare a given patient's attitudes with those of other 
patients, and will aid in identifying those most likely to 
benefit from special efforts directed toward compliance 
with treatment regimen. 
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Theoretical Foundations 
Through the mid-1960's, social scientists continued to 
assert the inconsistent relationship between attitudes and 
behavior. Evidence of the inconsistency began with 
LaPiere's now classic (although flawed) 1934 study of 
discrepancy between general attitudes toward minority groups 
and behavior toward a specific Chinese couple. Since the 
late 1960's, however, researchers armed with new theories 
and methodology have begun to study attitudes with renewed 
interest and even optimism (Kelman, 1974). Most current 
investigators accept the existence of an attitude-behavior 
relationship and concern themselves with the circumstances 
within which attitudes correlate with behavior. This 
section will address probability and latent process 
definitions of attitude, attitude measurement using 
commitment-free responses, the role of personal and 
situational variables in the attitude-behavior equation, 
and attitudes and behavioral compliance in view of the 
theoretical findings. (General methodological variables 
have also been found to influence conceptualization of the 
correlation between attitude and behavior, but their 
discussion is beyond the scope of this paper. For an 
excellent review of these factors, the reader is directed 
to Stewart's 1977 summary.) 
Definitions of attitude. DeFleur and Westie (1963) 
postulate that two general conceptions underlie historical 
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definitions of attitude. These categories are probability 
conceptions and latent process conceptions. Differences 
between them involve the inferences to be made about 
attitudinal responses. Adherents of the probability 
definition state that attitudinal responses are consistent 
in most situations; behavior toward a specific attitudinal 
stimulus has a probability of recurring in a particular 
direction. The latent process definitions take the 
probability concept a step further and give the behavior a 
hypothetical anchor. Latent process theorists see attitude 
as the mediating variable by which consistencies of 
behavior can be explained. To paraphrase Stewart (1977), 
probability theorists do not expect attitude-behavior 
consistency across situations because, while attitudes and 
behaviors might be correlated, they are caused by different 
variables. Attitude-behavior inconsistency is an issue for 
the latent process theorists, on the other hand, because, 
since attitude is for them an intervening variable, it is 
one of the causes of behavior. 
Attitude measurement using commitment-free responses. 
The purpose of defining attitude is to enable its 
measurement. This investigation used a model for attitude 
measurement based on latent process theory. Goodmanson and 
Glaudin in 1971 proposed a suitable paradigm which used as a 
measurement criterion the amount of commitment a response 
carries. They proposed that response consequences lie on a 
commitment-free to committed behavior continuum. In the 
Goodmonson and Glaudin model, attitude is a latent or 
intervening variable which can be inferred from 
commitment-free responses to an attitude test. Because 
attitude is viewed as one of the causes of behavior, in 
this model attitude-behavior inconsistency can be 
attributed to the impact of other variables on behavior. 
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Using the latent process definition of attitude, the 
problem of measuring attitudes toward psychiatric medicine 
becomes one of developing a reliable instrument which would 
permit commitment-free responses concerning the referent 
subject. Much attitude research has examined racial, 
political, and religious issues, subjects which are 
constrained by powerful social behavioral guidelines. In 
comparison, the topic of psychiatric medicine is relatively 
free of inherent social expectancies and therefore seems an 
appropriate psychological object for attitude research. 
Personal and situational variables. Before the 
mid-1960's, personal and situational variables were deemed 
error variance in most attitude research (Fishbein, 1967). 
More recently, researchers have begun to include 
investigation of personal and situational variables in their 
examinations of the attitude-behavior correlation (Liska, 
1975). Empirical evidence supports this theoretical 
shift. In her review, Stewart (1977) found that personal 
variables such as verbal skills, intellectual and social 
abilities, activity level, self-perception as a doer, ego 
involvement, and deliberate inconsistency, influenced the 
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attitude-behavior relationship. While intuitively and 
empirically, individual factors appear to affect behavior, 
a computer-aided literature· search yielded no reports of 
studies concerning the effect of these types of personal 
variables on attitudes of psychiatric patients. 
Attitudes have been further categ9rized as attitudes 
toward the specific object, toward the action itself, and 
toward the situation (Kelman, 1974). Normative beliefs 
also have been suggested as a situational variable which 
may influence the attitude-behavior relationship (Fishbein, 
1 967) . 
On the basis of previous literature, this author 
expected attitudes toward psychiatric medicine, toward 
taking psychiatric medicine, and toward being in a situation 
in which psychiatric medication thera.py is indicated, to be 
some of the attitudinal variables which interact with 
certain personal variables to influence a psychiatric 
patient's medicine-taking. Further, beliefs of his or her 
peer or cultural groups likely influence the individual's 
attitude toward the referent object. It would be 
efficacious to include these variables in any examination 
of the factors thought to affect the attitude-behavior 
correlation. 
Attitudes and compliance. As noted earlier, latent 
process attitude theory suggests that attitude is one of the 
intervening and personal variables which have been found to 
influence any action situation. It also was noted that a 
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literature review revealed that the topic of attitudes of 
psychiatric patients toward specific aspects of psychiatric 
medicine and psychiatric medicine-taking has been ignored 
by scientific journals. Other research suggests that 
attitude toward psychiatric medicine can be determined from 
responses to a commitment-free questionnaire. This study 
proposed to develop an attitude scale for use in future 
research examining the effect of attitudes on psychiatric 
patients' medicine-taking behavior. Attitude theory and 
data from empirical investigations indicate that such a 
scale would be enhanced by inclusion of statements 
concerning attitudes toward psychiatric medicine, toward 
taking such medication, toward being required to take 
psychiatric medication, and influences from the normative 
group. 
If a reliable questionnaire were devised, this would 
be a tool to facilitate research on several unanswered 
questions. An attitude questionnaire would be useful in 
determining the parameters of a psychiatric patient's 
attitudes toward his or her therapy, would allow 
comparisons of the patient to other groups, and would 
initiate the study of the influence of attitude on 
compliance with prescribed therapy regimen. Given good 
validity data, potential uses of an attitude scale would 
include the differentiation of patients likely to be 
non-compliers from the remaining psychiatric population. 
CHAPTER III 
METHOD 
Part I-Scale Development 
Subjects. The development of the questionnaire item 
pool began by interviewing 15 patients undergoing medical 
and psychological treatment for depression and anxiety in 
various treatment facilities. Inpatient facilities 
included a rural state hospital 20 miles from a medium-
sized city in the Pacific northwest and a Veteran's Admin-
istration Hospital in that ~ity. The other setting was a 
pr.ivate outpatient clinic operated by a psychiatrist and 
a clinical psychologist in the same·city. The average age 
of the eight female patients was 39.6 years, of the seven 
males, 34.9 years. Of these patients, five women and 
six men had prior psychiatric medicine experience. 
Instrument. A structured interview was constructed 
which covered specific and general attitude content dimen-
sions. The interview included questions regarding 
general attitude toward taking psychiatric medicine, 
vulnerability toward illness, efficacy of psychiatric 
medicine, pleasant and unpleasant aspects of psychiatric 
medicine, schedule followed when prescribed medicine, 
factors which enhanced or inhibited schedule adherence, 
changes experienced if any, and attributions about the 
changes when taking psychiatric medicine or failing to take 
psychiatric medicine (see Appendix A). 
Analysis and development of scale for Part II. Upon 
analysis, patient responses to the structured interview 
appeared to fall into six content dimensions: fear of 
physical addiction, fear of emotional dependency, the use 
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of psychiatric medicine as covering up problems, risk versus 
safety of the medicine, trust in the h€lping professional, 
and obligation or duty to take prescribed medicine. To 
generate additional material, concepts from attitude and 
health education literature were used-to supplement the 
above data. Questions in four areas, the influence of 
significant others, belief in medicine efficacy, the need 
for information about the medicine, and the belief that 
medicine improved cognitive efficiency, were added. 
Finally, items from the Health Belief Model were included 
as the 11th content dimension (Rosenstock, 1974). These 
latter items concerned general health motivation, perceived 
susceptibility toward the illness, perceived severity of 
the illness, and probability that compliant behavior would 
reduce threat of illness. All items were constructed using 
as much original wording from the structured interview data 
as possible. Sentences were written in brief and 
self-referent form. (See Appendix B for a copy of this 
177-item questionnaire.) 
The 177 items were evaluated by eight health care 
professionals for expression of positive, negative, or 
ambiguous attitude toward psychiatric medicine, after 
Thurstone (1931 ). Judges' agreement about expression of 
valence was tabulated for each item. Four items 
consistently judged positive and four judged negative were 
extracted from each content dimension, building a list of 
80 items. (See Appendix C for 80-item PMAS.) The Health 
Belief Model items yielded inconsistent ratings from the 
judges and were deleted from the item pool at this stage. 
Part II-Scale Refinement 
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Subjects. Subjects for the scale refinement phase 
were 126 introductory psychology college students enrolled 
at a metropolitan state university in the same city 
mentioned earlier, and 30 outpatients rec~iving medical and 
psychological treatment for depression and anxiety in the 
previously noted clinic. Questionnaires with more than 10 
percent of the questions unanswered were discarded. Six 
student questionnaires and one outpatient form were 
unusable, resulting in usable questionnaires from 149 
subjects. 
Of these, 65 subjects met the criterion for inclusion 
in the "experienced" sample; the criterion for inclusion was 
experience regarding psychiatric medicine, either reported 
personal experience and/or experience through that of a 
close friend or relative. The experienced subjects (30 
21 
outpatients and 35 students) included 33 females and 32 
males, mean ages of 32.33 years. The naive subjects, n = 
84, included 43 females and 41 males with an average age of 
23.88 years. The experienced subjects as a group were 
significantly older (p < .001) than the medicine-naive 
subjects. 
Instrument. The 80-item PMAS was used. Items were 
rated on a six point scale from "strongly agree" (1) to 
"strongly disagree" (6). An informed consent form was 
attached to each questionnaire following university 
procedure. Although signatures were required on the consent 
forms, anonymity was secured by detaching the consent forms 
from the questionnaires before data analysis. 
Procedure. Students were administered the 
questionnaire during regular class time. Subjects from the 
outpatient clinic completed the questionnaire at the time of 
their initial visit. Questionnaires typically required 10 
minutes for completion. Data collection proceeded for six 
months from December 1978 through May 1979. 
Analysis. The resulting data were analyzed in a four 
step process of scale refinement. 
The descriptive data were analyzed first. Frequency 
distributions of item responses were examined and responses 
of the experienced and naive subjects were contrasted on a 
per item basis using two-tailed t tests. 
Then, correlation matrices for the 80 PMAS items were 
computed for each group separately (experienced = E, and 
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naive= N) and together (T). The three resulting 80 x 80 
matrices were factor-analyzed using the principle components 
method. After initial factoring, the factors having 
eigenvalues of 1 .000 and greater were rotated to an 
orthogonal Kaiser normalized Varimax solution for each 
group. Prominent factor patterns were noted. 
Third, factor patterns from the E, N, and T data were 
compared. Items with loadings of ~40 and greater were 
selected from prominent and content-similar factors for E 
and T groups. Alternate forms, designated Forms A and B, 
comprised of 25 items each were developed. 
Finally, Pearson product-moment correlations were 
computed to examine the item-total correlations for each of 
the preliminary 25-item versions of the PMAS. The 25-item 
scales were pared to 20-item final versions. Alternate 
form reliability was computed by correlating total scores 
of the 20-item version of Form A with that of Form B. 
CHAPTER IV 
RESULTS 
The following results were obtained from responses of 
the 149 subjects to the 80-item PMAS. Results from each 
step of scale development, analysis of descriptive data, 
factor analyses, alternate form construction, and scale 
refinement, are described. 
Descriptive Data 
Item means ranged from 1.70 to 5.20 on the six point 
scale from strongly agree (1) to strongly disagree (6). The 
experienced subjects expressed consistently greater re-
sponse variability than did the naive subjects. 
The experienced subjects responded in a significantly 
different direction, E. (. 01, than the naive subjects on 
54% of the items. List I shows examples of items on which 
the E mean response differs from that of the N mean 
response. 
To summarize their differences,. the experienced 
subjects tended to agree with items which expressed more 
confidence in medical help, more willingness to follow 
medication directions, less fear of possible physical and 
cognitive side-effects from psychiatric medication, less 
fear of addiction, and less concern about social censure 
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UST I 
DIRECTIONAL DIFFERENCES OF ITEM RESPONSES 
XE xN E subjects agreed more than N subjects: 
1.49 1.92 If psychiatric medicine were prescribed for me, 
I would follow the directions carefully. (8) 
2.86 2.46 I feel it would be necessary for me to comply 
with a prescription for psychiatric medica-
tion. (10) 
2.91 3.42 I would put up with some uncomfortable medica-
tion side-effects in order to get over a 
serious depression. (14) 
3.31 3.75 Psychiatric medicine might give me the energy 
to think clearly if I were depressed. (18) 
2.37 2.99 I think some problems can be faced up to better 
with the support of psychiatric medica-
tions. (36) 
3.02 3.38 I would take psychiatric medication prescribed 
for me because I think it is pretty effec-
tive. ( 40) 
4.43 4.79 When I have emotional problems, I want psychi-
atric medicine prescribed for me. (48) 
2.34 3.01 I take my medication regularly regardless of 
what my family thinks of it. (53) 
2.00 2.62 I think it's always best to seek medical help 
for severe depression. (61) 
2.56 3.21 Psychiatric medicines which are prescribed by 
a doctor have been carefully screened by 
scientific studies. (65) 
3.52 4.18 I have no qualms about trying psychiatric medi-
cation my doctor recomends. (68) 
2.43 3.10 I think a patient should take prescribed psychi-
atric medicine even if family and friends 
don't understand. (69) 
3.97 4.55 I'll try whatever psychiatric medicine my 
doctor recommends. (72) 
2.31 2.81 Other people's opinions would never stop me 
from taking the medication I need. (80) 
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LIST I (con'd) 
xE xN E subjects disagreed more than N subjects: 
3.62 3.15 Psychiatric medicines usually cover up problems 
that should be faced. (5) 
4.25 3.64 Even carefully prescribed psychiatric medicines 
are much too risky. (9) 
4.55 3.70 I don't believe in psychiatric medicines. (12) 
2.94 2.56 Psychiatric medications are habit-forming. (13) 
3.80 3.13 I believe all psychiatric medicines present a 
very real danger of addiction. (16) 
5.60 5.23 Whether you take prescribed psychiatric medicine 
exactly as directed just isn't very impor-
tant. ( 17) 
3.42 2.98 I believe people should face their problems 
without psychiatric medicine. (19) 
5.15 4.57 Unless friends kept encouraging me to take 
prescribed psychiatric medicine, I would 
stop. (22) 
4.03 3.56 I would not take prescribed psychiatric medi-
cines because they take the edge off my 
thinking. ( 24) 
4.77 4.25 The only value psychiatric medicine has comes 
from the power of suggestion. (26) 
3.74 2.89 I'm afraid that if I took a prescribed psychi-
atric medicine, I would become dependent 
on it. (28) 
2.54 1.94 A patient should reject psychiatric medication 
unless every detail is explained care-
fully. ( 30) 
3.08 2.60 I think it's wrong to take medicine all the 
time because if your thinking is dulled, 
you don't have a good sense of when you're 
well. (31) (Item withdrawn from consider-
ation.) 
3.49 2.96 Having to take psychiatric medicines is no way 
to live. ( 33) 
LIST I ( con ' d) 
xE xN 
5.06 4.37 I would not take prescribed psychiatric medi-
cation even if every detail were explained 
to me. ( 37) 
4.88 4.46 If my family seemed uninterested in my treat-
ment, I would throw prescribed psychiatric 
medicine down the sink. (42) 
5.00 4.33 I would not take psychiatric medication pre-
scribed for me if my family and friends 
seemed very interested. (44) (Item 
withdrawn from consideration.) 
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3.71 3.31 I believe psychiatric medication usually makes 
thinking fuzzy. (45) 
2.06 1.60 I would be hesitant to take psychiatric medica-
tion prescribed for me without knowing all 
about it. ( 4 7) 
4.88 4.18 I don't care how safe a psychiatric medication 
is reported to be, I still wouldn't take 
it. ( 50) 
4.58 3.74 I believe psychiatric medicines basically 
poison the body. (54) 
4.68 4.17 Psychiatric medicines are too weak to help 
treat big problems. (58) 
2.77 2.27 I see psychiatric medicine as a last resort to 
coping with emotional problems. (63) 
3.98 3.24 You can't expect a patient to take psychiatric 
medication if no one cares. (64) 
3.77 2.95 Even though psychiatric medicine might help 
with emotions, it usually makes it harder 
to think clearly. (67) 
3.97 3.36 I think psychiatric medications almost always 
block you from having feelings you should 
experience. (70) 
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LIST I (con ' d) 
xE xN 
3.66 3.13 Once you begin taking psychiatric medicine, it 
is hard to give it up. (73) 
4.85 4.26 All the medical information in the world 
couldn't convince me to take psychiatric 
medication. (75) 
Note. 1 = strongly agree; 6 = strongly disagree. Numbers 
in parentheses at the end of each item indicate the 
item number on the 80-item PMAS. 
regarding taking prescribed psychiatric medicine, than did 
the medicine-naive subjects. 
Factor Analyses 
An examination of the factor patterns for the 
experienced and naive subjects and for the total group was 
made for the purpose of selecting items for the final 
scale. In this process, somewhat more emphasis was placed 
on the results of the factor pattern of the experienced 
subjects. This was done because of the observation that 
many patients beginning psychiatric outpatient treatment 
had had prior somatic therapy elsewhere (Glaudin, 1979). 
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It seemed likely that the attitude patterns of the 
medicine-experienced subjects would correlate best with 
those of the population on which the questionnaire 
eventually would be used. In developing the content 
dimensions, those prominent factors from the pattern of the 
experienced subjects which included at least two items with 
high and/or similar loadings were selected. The latter 
criterion was used for the purpose of developing two 
alternate forms. Corroboration of the resulting content 
dimensions was sought within the factor patterns of the 
total group. The factor patterns of the total sample 
appeared to parallel considerably the ten factors from the 
experienced subject sample. 
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Analysis of the factor patterns yielded ten prominent 
factors. These were labeled, (a) information, (b) dangers, 
(c) coping, (d) need, (e) remembering, (f) addiction, (g) 
details, (h) friends, (i) authority, and, (j) emotions. 
List II shows sample items from each factor. 
Alternate Form Construction (25-item PMAS) 
Through the process of factor analysis described in 
the methods section, items suitable for inclusion in 
alternate forms of a preliminary (25-item) PMAS were 
derived. A number of quantitative and qualitative criteria 
for item selection were used. Desirable items were those 
which (a) met Thurstone (1931) analysis criteria (low 
ambiguity), (b) represented all categories of endorsement, 
(c) represented the 10 content dimensions, and (d) had 
varying degrees of content specificity. In addition, items 
on which the experienced subjects differed significantly 
from the medicine-naive subjects were balanced with items 
on which the two groups responded similarly. The last 
criterion was style, with briefer and self-referent items 
being preferred. Lists III ~nd IV show the 25 items of 
Forms A and B of the PMAS. 
As can be seen from Tables r-and II, three items (53, 
56, and 63) of the final 50 selected did not have loadings 
on .40 or higher in the factor pattern of the total group. 
1. Information 
LIST II 
SAMPLE ITEMS 
Once I had the medical facts carefully explained to 
me, I would take necessary psychiatric medication. 
2. Dangers 
I think psychiatric medicines usually have bad side 
effects. 
3. Coping 
Psychiatric medicine can help provide the energy to 
face overwhelming problems. 
4. Need 
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I would take psychiatric medication I needed whether 
I liked the doctor or not. 
5. Remembering 
It is easy for me to neglect taking my medication 
when I get busy. 
6. Addiction 
Psychiatric medications are habit-forming. 
7. Details 
A patient should reject psychiatric medication unless 
every detail is explained carefully. (Omitted in 
final PMAS.) 
8. Friends 
Unless friends kept encouraging me to take prescribed 
psychiatric medicine, I would stop. (Omitted in final 
PMAS.) 
9. Authority 
I have no qualms about trying psychiatric medication 
my doctor recommends. 
10. Emotions 
I would be relieved to find out that a close friend 
was taking medication for depression. 
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LIST III 
LIST OF 25-ITEMS ON FORM A l}F THE PMAS 
Factor 1. Information 
Once I had the medical facts carefully explained to me, 
1 would take necessary psychiatric medication. (35) 
I would not take prescribed psychiatric medication even 
~f every detail were explained to me. (37) 
I think a patient should take prescribed psychiatric 
medicine even if family and friends don't under-
stand. (69) 
I don't believe in psychiatric medicines. (12) 
I would put up with some uncomfortable medication side-
effects in order to get over a serious depression. (14) 
Even carefully prescribed psychiatric medicines are much 
too risky . ( 9 ) 
I would take psychiatric medication prescribed for me 
because I believe it is pretty effective. (40) 
The trouble with psychiatric medicines is that they just 
don't work. (38) 
Factor 2. Dangers 
Once you begin taking psychiatric medicine, it is hard 
to give it up. (73) 
I think psychiatric medicines usually have bad side 
effects. ( 34) 
·Even though psychiatric medicine might help with emotions, 
it usually makes it harder to think clearly. (67) 
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LIST III (con'd) 
Factor 3. Coping 
I believe prescribed psychiatric medicines usually would 
make a patient's thinking clearer because of less 
anxiety. ( 74) 
·Psychiatric medicine can help provide the energy to face 
overwhelming problems. (46) 
I believe psychiatric medications can make it po~sible 
to learn new behavior in frightening situations. (77) 
Factor 4. Need 
I would take prescribed psychiatric medication for the 
sake of my loved ones. (7) 
It would be impossible for me to take psychiatric medi-
cine from a doctor I didn't trust. (62) Omitted 
Factor 5. Remembering 
It is easy for me to neglect taking my medication when 
I get busy. (55) 
No matter how busy I get, I always remember to take my 
medication on time. (43) Omitted 
Factor 6. Addiction 
·carefully prescribed psychiatric medicines have no 
danger of addiction. (41) Omitted 
Whether you take psychiatric medicine exactly as pre-
scribed just isn't very important. (17) 
Factor 7. Details 
A patient should reject psychiatric medication unless 
every detail is explained carefully. (30) Omitted 
LIST III (con'd) 
Factor 8. Friends 
Unless friends kept encouraging me to take prescribed 
psychiatric medicine, I would stop. (22) Omitted 
Factor 9. Authority 
I would take psychiatric medication prescribed for me 
and not worry about scientific details. (56) 
I have no qualms about trying psychiatric medication 
my doctor recommends. (68) 
Factor 10. Emotions 
33 
I would be relieved to find out that a close friend was 
taking medication for depression. (15) 
Note. Numbers in parentheses at the end of each item 
indicate the item number on the 80-item PMAS. 
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LIST IV 
LIST OF 25-ITEMS ON FORM B OF THE PMAS 
Factor 1. Information 
Having the scientific information would in~luence me to 
take psychiatric medication prescribed for me. (39) 
I don't care how safe a psychiatric medication is reported 
to be, I still wouldn't take it. (50) 
·If the doctor explains what effects the medicine might 
have on me, I would take it as prescribed. (59) 
All the medical information in the world couldn't con-
vince me to take psychiatric medication. (75) 
I think some problems can be faced up to better with the 
support of psychiatric medications. (36) 
Psychiatric medicines usually cover up problems that 
should be faced. (5) 
I think taking psychiatric medicine is a realistic method 
to lessen discomfort. (20) 
I would rather have psychological counseling forever than 
take psychiatric medicines. (23) 
Factor 2. Dangers 
I'm afraid that if I took a prescribed psychiatric medi-
cine, I would become dependent on it. (28) 
I believe psychiatric medication usually makes thinking 
fuzzy. (45) 
-I think psychiatric medications almost always block you 
from having feelings you should experience. (70) 
Factor 3. Coping 
Psychiatric medicine might give me the energy to think 
clearly if I were depressed. (1) 
I think prescribed psychiatric medication can help 
patients concentrate better. (52) 
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LIST IV (con'd) 
Frequently, patients can learn new ways of coping because 
psychiatric medicines break up old anxiety patterns. 
(66) 
Factor 4. Need 
·I would take psychiatric medication I needed whether I 
liked the doctor or not. (60) 
I would never take psychiatric medicine from a doctor 
I didn't have full confidence in. (27) Omitted 
Factor 5. Remembering 
It would be easy for me to forget to take my medicine. 
(76) Omitted 
I take my medication regularly regardless of what my 
family thinks of it. (53) 
Factor 6. Addiction 
·One of the best things about most psychiatric medica-
tion is that there is no risk of addiction. (21) 
Psychiatric medications are habit-forming. (13) 
Factor 7. Details 
A patient should reject psychiatric medication unless 
every detail is explained carefully. (30) Omitted 
Factor 8. Friends 
Unless friends kept encouraging me to take prescribed 
psychiatric medicine, I would stop. (22) Omitted 
36 
LIST IV (con'd) 
Factor 9. Authority 
I'll try whatever psychiatric medicine my doctor recom-
mends. (72) 
I would be hesitant to take psychiatric medication pre-
scribed for me without knowing all about it. (47) 
Factor 10. Emotions 
I see psychiatric medicine as a last resort to coping 
with emotional problems. (63) Omitted 
Note. Numbers in parentheses at the end of each item 
indicate the item number on the 80-item PMAS. 
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Scale Refinement 
To reduce the time required for completion of the 
PMAS, the number of attitude questions was limited to 20 on 
each form. Pearson product-moment correlations were 
performed on each 25-item form. Item-total correlations 
for the 25-item Form A ranged from .78 to .23 with a median 
correlation of .54. Item-total correlations for the 
25-item Form B ranged from .76 to .31 with a median of .60. 
The five items having the lowest correlations with 
total score were deleted from each scale. As Table II 
shows, items 22, 30, 41, 43, and 62 were omitted from the 
25-item Form A. Items 22, 27, 30, 63, and 76 were dropped 
from the 25-item Form B. 
Pearson pruduct-moment item-total correlations were 
rerun on the 20-item scales. The item-total correlations 
on the final version of Form A ranged from .80 to .30 with 
a median correlation of .5s. The 20-item Form B item-total 
correlations ranged from .75 to .42, and had a median 
correlation of .62. (See Appendix D for copies of the 
20-item PMAS scales.) 
These calculations reflect the moderate to strong 
degree of internal consistency of each scale. Reliability 
between the 20-item Forms A and B was .93, significant at 
the p < .001 level. The mean score for the experienced 
subjects on the 20 items which comprise Form A was 2.85, 
and on the 20 which make up Form B, was 3.17. The mean 
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score for the naive subjects on the 20-item Form A was 3.40 
and on the Form B, was 3.51. Again, greater response 
variability of the experienced subjects was noted. In 
summary, reliability checks showed adequate internal 
reliability between the alternate forms. These data 
demonstrate that the task of developing an easily 
administered and reliable commitment-free instrument to 
measure attitudes toward psychiatric medicine among 
medicine-experienced and medicine-naive patients was 
accomplished. 
CHAPTER V 
DISCUSSION 
These results describe the development of a paper and 
pencil scale evaluating attitudes toward psychiatric 
medicine. The investigation revealed that several content 
dimensions emerged from the data on attitudes. It also 
appeared that individuals with prior personal or vicarious 
experience with the referent object tertded to respond to 
the questionnaire in a qualitatively different manner and 
with more variability of endorsement per item than did 
those with no prior psychiatric-med~cine experience. 
Scientific literature indicates the possibility of 
predicting behavior once attitudes, as measured on a 
commitment-free instrument, are known. This section will 
discuss content of the attitude dimensions, the factor 
patterns which resulted, reliability of the results 
obtained, as well as directions for future research with, 
and use of, the PMAS. 
Content Description 
As noted earlier, the medicine-experienced subjects 
responded differently than did the medicine-naive subjects 
to the instrument. In general, although their response 
variability was greater, the experienced subjects responded 
more positively toward the referent topic. The more 
positive response pattern was evident in both general and 
specific item content. Experienced individuals disagreed 
strongly (mean responses of 4.55 and 4.58, respectively) 
with global items such as, "I don't believe in psychiatric 
medicines," and, "I believe psychiatric medicines basically 
poison the body." At a more specific content level, they 
agreed (mean responses 1.49 and 2.00, respectively) with 
items of this type: "If psychiatric medicine were 
prescribed for me, I would follow the directions 
carefully," and, "I think it's always best to seek medical 
help for severe depression." 
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A closer examination of the descriptive statistics 
shows- the more positive attitude of the experienced group 
to have several components. The experienced group endorsed 
items which indicated (a) willihgness to comply with 
medication instructions, (b) belief in the efficacy of 
psychiatric medicine (specifically that it helps one face 
problems and permits clear thinking), (c) trust in the 
scientific information about the safety of psychiatric 
medicine, (d) disregard for possible somatic or cognitive 
side-effects, (e) minimal fear of addiction to.psychiatric 
medicine, and, (f) disregard of social censure for taking 
psychiatric medicines. These findings suggest that 
previous experience with the attitude object minimizes some 
general prejudices about psychiatric medicine, such as that 
it covers up problems, clouds one's thinking and is 
addictive. 
In discussing the more positive attitudes of the 
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experienced subjects, it is important to note again the 
mean age differences between the two samples. The 
experienced subjects tended to be in their early 30's and 
the naive subjects tended to be in their early 20's. The 
influence of age in this measurement of attitude toward 
psychiatric medicine remains unclear. Since the group of 
medicine-experienced subjects is relatively small (n = 65) 
the argument could be made that a restricted sample was 
obtained. H.owever, it is likely that, as a function of 
living independently and facing life's traditional 
stressors such as jobs and significant relationships for a 
longer period of time, more people in the older sample will 
have sought psychiatric help for emotional problems than in 
the younger group. It is possible that experience with the 
referent or therapy in general as well as a tendency to 
think more flexibly as one matures, apparent in their more 
varied responses, fostered the more positive attitude shown 
by this sample of medicine-experienced individuals. While 
it is also possible to speculate that the attitudes of the 
older, experienced subjects had evolved from a more 
negative position such as that endorsed by the younger, 
naive subjects, it is impossible to verify this hypothesis 
without a longitudinal study or at least a retrospective 
pretest. Even then, the validity of the latter could be 
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questioned. The former was unfortunately outside the realm 
of this research and will remain for future investigations. 
Information about dimensions of attitudes toward 
psychiatric medicine and differences in attitude as a 
function of experience or age could be useful to 
professionals who treat psychiatric patients. If validity 
work on the PMAS establishes a relationship between 
attitude toward psychiatric medicine and compliance with 
therapeutic regimen, scale results could help close the gap 
between therapists' assumptions and patients' behavior 
noted in the introduction of this report. 
These results imply that the patient-doctor 
relationship is important in subtle ways as the patient 
builds experience with ~sychiatric medicine. The large 
body of psychological research on placebo effects supports 
this implication. Attitudes could be influenced by how the 
patient is treated by the prescribing professional, the 
professional's confidence in the medicine, the competence 
and caring shown by the staff; it could be that simple 
conditioning accounts for the attitudes expressed and that 
any internal stimulus or external event contiguous to the 
medicine-taking could influence the regard with which the 
individual holds the experience. This is a fertile area 
for research. In any case, it is obvious that the 
patient-doctor relationship carries much potential for 
influencing beliefs and thoughts. It seems plausible that 
these influences affect behavioral intentions toward 
psychiatric medicine and treatment adherence. 
Factor Patterns 
Because of the modest sample size, generalizations 
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from the factor analyses are presented as suggestions for 
dimensions of attitude patterns. The results of this study 
show clearly, however, that the attitudes toward psychiatric 
medicine are multidimensional. The relationship between 
positive and negative attitudes is not simply a linear one 
stretching from positive feelings at one pole and negative 
attitudes on the opposite. Rather the options surveyed 
seem rich and intercorrelated. In addition, responses of 
individuals with different medicine-taking histories 
suggest future differences in commitment behavior, such as 
compliance with medication regimens and perhaps even 
therapy outcome. 
The factor patterns basically support the original 10 
experimental content dimensions. For our samples, attitudes 
toward psychiatric medicine include these dimensions: (a) 
feelings about trusting scientific information about 
psychiatric medicine, (b) fears of somatic and cognitive 
dangers from taking psychiatric medicine, (c) belief that 
medicine helps one handle problems of living, (d) need for 
the medication, (e) feelings about remembering to take 
prescribed medication as directed, (f) beliefs about 
psychiatric medicine's potential for addiction, (g) need to 
have details about the medicine explained, (h) feelings 
about the influence of friends and family upon 
medicine-taking behavior, (i) belief in the attending 
authority to prescribe the best medicine for the patient, 
and (j) belief in the efficacy of medicine for specific 
complaints such as depression or anxiety. 
The PMAS attempted to capture the complexity of these 
attitudes by representing these content dimensions in the 
final version of the scale. This project is an initial 
study, and it is hoped that future research will 
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investigate the accuracy and predictive validity of the 
content dimensions of the scale. Of special interest is a 
model of the attitude structure of compliant and 
noncompliant patients. The factors obtained in this 
investigation begin to outline the range and content of 
attitudes patients have toward psychiatric medicine. These 
analyses suggest that the development of a cognitive model 
for attitudes toward psychiatric medicine is possible. Even 
before extensive validity testing of the instrument and 
development of norms, it appears that the PMAS can have 
utility in a clinical setting. 
Reliability 
As noted in the results section, the internal and 
alternate forms consistency was good. The scale was found 
to be a reliable instrument for the sample tested. 
Directions for Future Research 
As noted earlier, the validation of the PMAS remains 
to be done. In addition, the results obtained in this 
investigation suggest several areas for continued research 
with the scale. 
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Because the normative sample is small, the development 
of more extensive norms is advised. It is also suggested 
that future research focus on verifying the reliability 
through more extensive standardization and investigating 
more thoroughly the affective components of attitude. It 
is expected that obtaining PMAS scores on a larger number 
of medicine-experienced patients will produce a somewhat 
lower response variability within this group as a whole. 
Standardization on a larger sample would also permit more 
extensive examination of the factor patterns found in this 
exploratory work. If a relationship is found between 
positive attitude as measured by the PMAS and compliance 
with regimen, it will be interesting to evaluate the 
differences in the attitude factors endorsed by both 
experienced and naive individuals. More conclusive 
evaluation of the factor patterns would be possible given 
larger norms. 
Another area for future research is in the development 
of specific scales or subscales for different presenting 
complaints. For example, factor 10 was interesting because 
the only apparent relationship among its items was that 
each sentence contained the word "depression" or the word 
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"anxiety." This suggests that these specific words cue 
certain beliefs or feelings, indicating possible 
differences in the patterns of attitudes about general 
psychiatric treatment and treatment for specific complaints 
such as anxiety or depression. If validity work results in 
the expected relationships between attitude and treatment 
compliance, it might prove useful to develop separate 
scales for different presenting disorders. Since in 
attitude measurement, it is believed that the more specific 
the referent topic, the more predictive the scale, PMAS's 
for complaints of depression, pain, or anxiety, could have 
definite clinical utility (Kelman, 1974). 
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APPENDICES 
APPENDIX A 
INITIAL STRUCTURED INTERVIEW 
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INITIAL COMPLIANCE INTERVIEW WITH PSYCHIATRIC OUTPATIENTS 
We are involved in a research study investigating how people 
feel about taking psychiatric medicine. This study is 
designed to find out the relationship between attitude and 
following the medication directions. 
Your information is a critical part of this study. From the 
information you give us, we hope to build the basic 
questionnaire of the study. The questionnaire developed 
from your information will be used to survey a large number 
of people who, for differing reasons, are taking 
psychiatric medicine. The interview has 16 questions about 
how you feel about taking medicine, what things help you 
take it on time, what prevents you from taking it, and what 
changes you feel because of the medicine. 
During this interview, we hope that you will represent your 
own thinking and feelings, as well as what you think others 
believe. 
Do you have any questions? If not, let's start the 
interview. 
1. In general, how would you describe your attitude 
toward taking psychiatric medicine? 
1a. What do you think about other people taking 
psychiatric medicine? 
1b. · What do you think of taking medication for 
nervousness (anxiety), depression, or 
sleeplessness? 
2. Some people feel vulnerable to illness. 
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b 1"11?. 2a. In general, how likely is it that you ecome 
2b. If you do get sick, how severe do you expect the 
illness to be? 
2c. How worried would you be if a close friend your 
age became depressed? 
3. To what extent do you feel that taking psychiatric 
medicine is helpful in treating depression? 
4. Taking medicine has some aspects that are more pleasant 
than others. 
4a. What about taking psychiatric medicine is 
pleasant? 
4b. What about taking psychiatric medicine is 
unpleasant? 
5. When you are given a prescription, what kind of 
schedule do you tend to follow for taking the medicine? 
6. What sorts of things prevent you from taking medication 
as prescribed? 
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7. What kinds of things help you with taking the medicine 
on schedule? 
8. What kinds of changes do you experience when you take 
psychiatric medicine that has been prescribed for you? 
Sa. If there has been a change in the way you felt 
since beginning treatment, to what do you 
attribute these changes? 
9. What changes occur when you fail to take psychiatric 
medicine that has been prescribed for you? 
10. Is there anythirgelse that I've forgotten to ask you 
about taking psychiatric medicine? 
APPENDIX B 
177-ITEM ATTITUDE QUESTIONNAIRE 
61 
MEASURING ATTITUDES TOWARD TAKING PSYCHIATRIC MEDICATION 
Questions for reviewers: 
1. Is the item readable? If not, how could it be improved? 
2. Does the item express a positive or negative attitude? 
Please put a plus sign, minus sign, or a question mark 
in front of each item to tell us if you think the 
attitude conveyed is positive, negative, or unclear, 
respectively. 
3. What content areas have we left out? 
1. PHYSICAL ADDICTION 
Carefully prescribed psychiatric medicines have no danger 
of addiction. 
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One of the best things about most psychiatric medications is 
that there is no risk of addiction. 
I would be able to take psychiatric medications as 
prescribed with no risk of addiction. 
I believe all psychiatric medicines present a very real 
danger of addiction. 
I think most people tend to become physically dependent on 
the psychiatric medications prescribed for them. 
I'm afraid that if I took a prescribed psychiatric medicine, 
I would become dependent on it. 
I would take prescribed psychiatric medicine for a few days 
only. 
Most prescribed psychiatric medicines are safe to take over 
a period of months. 
I could take prescribed psychiatric medicines without 
becoming dependent on them. 
Psychiatric medications are habit-forming. 
Once you begin taking psychiatric medicine, it is hard to 
give it up. 
It is too easy to become dependent upon psychiatric 
medicine. 
I think it's unlikely that someone my age would become 
dependent upon psychiatric medicine. 
I think most people are afraid of the possibility of drug 
dependency. 
I would not worry about becoming addicted to a psychiatric 
medicine prescribed for me. 
I feel certain that taking psychiatric medicine for more 
than just a few days leads to physical dependency upon it. 
I'd be very afraid of getting hooked on psychiatric 
medicines. 
2. EMOTIONAL DEPENDENCY VS. STOIC INDEPENDENCE 
I don't like relying upon medication to solve emotional 
problems. 
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I would prefer to put up with my problems rather than take 
psychiatric medicine. 
I'd tend to rely on psychiatric medication less than other 
people do to solve my problems. 
Psychiatric medicine is only an emotional crutch. 
It is too easy for me to depend upon psychiatric medication 
to handle my emotions. 
I would be relieved to find out that a close friend was 
taking medication for depression. 
I believe people should face their problems without 
psychiatric medicine. 
I believe a person should be strong enough to live without 
psychiatric medications. 
Anyone who has chronic depression anticipates any help they 
can get to relieve it. 
I handle all my' problems without help from others. 
I don't believe in psychiatric medicines. 
I would rather suffer than use psychiatric medicine. 
I'm against psychiatric medicine because it is just a 
crutch. 
Psychiatric medication can help with all kinds of problems. 
Taking psychiatric medication is not the moral way to live. 
I would rather take psychiatric medicine than be extremely 
depressed. 
When I have emotional problems, I want psychiatric medicine 
prescribed for me. 
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I think taking psychiatric medicine means you are weak. 
In my opinion, taking psychiatric medicine is a lot better 
than having constant anxiety. 
I would rather commit suicide than take prescribed 
psychiatric medicine. 
Having to take psychiatric medicines is no way to live. 
I would be disgusted to find out that a friend of mine was 
taking psychiatric medication. 
Letting the depression run its natural course is the right 
way to get well. 
I think it's always best to seek medical help for severe 
depression. 
My life is too short to spend it suffering from emotional 
problems. 
I know that if I needed psychiatric medication to live, I 
would consent to it. 
A person would be a fool not to take psychiatric medicine 
when he really needs it. 
Taking psychiatric medicine would prove that I can't handle 
my problems on my own. 
3. COVER UP PROBLEMS VS. LEARN-FACE-FACILITATE 
Psychiatric medicines usually cover up problems that should 
be faced. 
I think some problems can be faced up to better with the 
support of psychiatric medications. 
I believe psychiatric medications can make it possible to 
learn new behavior in frightening situations. 
Frequently, patients can learn new ways of coping because 
psychiatric medicines break up old anxiety patterns. 
I would rather rely on psychological help and not take 
psychiatric medications prescribed for me. 
Psychiatric medication can help provide the energy to face 
overwhelming problems. 
Frequently, psychiatric medication counteracts 
discouragement so patients can tackle tough problems. 
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I think psychiatric medications make people too comfortable 
to face their problems. 
Psychiatric medicines seem to reduce people's motivation 
for new learning. 
I think psychiatric medications almost always block you 
from having feelings you should experience. 
I believe psychiatric medicines are prescribed too easily 
for routine problems. 
I would rather have psychological counseling forever than 
take psychiatric medicines. 
I see psychiatric medicine as a last resort to coping with 
emotional problems. 
Psychiatric medicine is there to make life easier for you. 
Taking psychiatric medicine conceals the problem. 
It's important to realize the limitations of psychiatric 
medicine. 
4. INFLUENCE OF SIGNIFICANT OTHERS 
I would take prescribed psychiatric medication for the sake 
of my loved ones. 
If my family seemed uninterested in my treatment, I would 
throw prescribed psychiatric medicine down the sink. 
Unless friends kept encouraging me to take prescribed 
psychiatric medicine, I would stop. 
You can't expect a patient to take psychiatric medication 
if no one cares. 
I think a patient should take prescribed psychiatric 
medicine even if family and friends don't understand. 
I take my medication regularly regardless of what my family 
thinks of it. 
If my family encouraged me, I would take psychiatric 
medication prescribed for me. 
If my spouse took medication regularly, I would be more 
inclined to take mine. 
My family always insisted that I take the medication 
recommended by my doctor. 
I would not take psychiatric medication prescribed for me 
if my family and friends seemed very interested. 
I prefer to follow my family's guidance about taking 
psychiatric medication. 
I would avoid the advice of friends in considering 
psychiatric medicines for my problems. 
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Other people's opinions would never stop me from taking the 
medication I need. 
5. EFFICACY 
Prescribed psychiatric medications are usually effective. 
Psychiatric medicines do little good in relieving important 
symptoms. 
I would take prescribed psychiatric medicines if they were 
more effective than they are. 
I would take psychiatric medication prescribed for me 
because I believe it is pretty effective. 
Psychiatric medicines are too weak to help treat big 
problems. 
The best thing about psychiatric medicines is that they 
work. 
The trouble with psychiatric medicines is that they just 
don't work. 
It's really all in your head; if you think a psychiatric 
medicine is going to work, it will work. 
The only value psychiatric medicine has comes from the 
power of suggestion. 
Being more relaxed is something you can count on from 
taking psychiatric medicines. 
Psychiatric medicines can help us return to a more normal 
way of living. 
I think taking psychiatric medicine is a realistic method 
to lessen discomfort. 
I see taking psychiatric medicine as necessary to a better 
functioning body. 
I'm convinced that it isn't natural to reduce emotional 
suffering by using psychiatric medication. 
I think it's a sad waste to deny a person the medicine 
necessary to good emotional health. 
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I think people should take psychiatric medicine if they're 
anxious and nervous. 
I see psychiatric medicine as a powerful tool in treating 
depression and nervousness. 
If I can't sleep, or if I get a headache, a mild 
tranquilizer is a good idea. 
6. RISK VS SAFETY 
Prescribed psychiatric medicines are not like other 
dangerous drugs which harm the body. 
Even carefully prescribed psychiatric medicines are much 
too risky. 
Psychiatric medicines do much more good than any minor harm 
they may cause. 
I believe psychiatric medicines basically poison the body. 
I think psychiatric medicines usually have bad side effects. 
I don't think psychiatric medicines are safe enough to be 
used with human beings. 
The risk of suicide is much greater than any risk in 
prescribed psychiatric medications. 
I would put up with some uncomfortable medication side 
effects in order to get over a serious depression. 
68 
In my opinion, any neeative side effects are minor compared 
to the good psychiatric medications do. 
Patients should be willing to put up with some physical 
discomfort from psychiatric medicines if the medicines can 
help. 
I believe psychiatric medicines are too dangerous. 
Even if a side effect is found in only one out of 100 
patients, I still would not take psychiatric medications. 
I don't care how safe a psychiatric medication is reported 
to be, I still wouldn't take it. 
By the time a psychiatric medication is ready to be used in 
practice, it is safe. 
Psychiatric medicines which are prescribed by a doctor have 
been carefullly screened by scientific studies. 
I can't accept the idea of ingesting chemicals, even in 
small doses, into my body. 
7. INFORMATION (OBSESSIVE) VS. NAIVETE 
A patient should reject psychiatric medication unless every 
detail is explained carefully. 
Once I had the medical facts carefully explained to me, I 
would take necessary psychiatric medication. 
All I need to know about psychiatric medicines is whether 
the doctor thinks I should take them. 
I would not take prescribed psychiatric medication even if 
every detail were explained to me. 
I would take psychiatric medicine prescribed for me and not 
worry about scientific details. 
If the doctor explains what effects the medicine might have 
on me, I would take it as prescribed. 
I would be hesitant to take psychiatric medication 
prescribed for me without knowing all about it. 
All the medical information in the world couldn't convince 
me to take psychiatric medication. 
Having scientific information could influence me to take 
psychiatric medication prescribed for me. 
8. TRUST VS. MISTRUST IN HELPING PROFESSIONAL 
I would take psychiatric medicine if I trusted the doctor 
who prescribed it. 
If the doctor listened to me carefully, I would take the 
psychiatric medicine he gave me. 
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I would follow through on taking psychiatric medicine if I 
liked the way the doctor treated me. 
Nothing is more important than trusting the doctor who 
prescribes medicine for me. 
It would be impossible for me to take psychiatric medicine 
from a doctor I didn't trust. 
If I did't like a doctor, I would reject medicine he wanted 
me to take. 
No one should take psychiatric medicine from an obnoxious 
doctor. 
I would take psychiatric medication I needed whether I 
liked the doctor or not. 
I would not take medicine from a doctor who was 
disrespectful. 
I believe in taking prescribed medicine even if the doctor 
seems uncaring. 
I'll try whatever psychiatric medicine my doctor recommends. 
I have no qualms about trying psychiatric medication my 
doctor recommends. 
I think most people trust their doctors to know about 
medications. 
I would never take psychiatric medicine from a doctor I 
didn't have full confidence in. 
I've always felt it was important to follow doctor's orders 
about medication. 
If I have faith in my doctor, I always take the medication 
prescribed for me. 
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Having a doctor who cares is the first step toward getting 
well. 
I've never taken medicine out of worry about the doctor's 
opinion. 
I would take psychiatric medications prescribed by a 
competent doctor even if he seemed uncaring. 
9. CAREFULNESS/GUILT/DUTY VS. CASUALNESS 
I feel guilty when I don't take prescribed medications on 
schedule. 
I trust my own judgement about when to take my medication 
rather than following a schedule. 
I take my medicine when I feel like taking it. 
I never take my medicine before I think I need it, no 
matter what the written instructions are. 
I get a guilty conscience if I don't follow my medication 
instructions. 
My conscience nags me if I don't take my prescribed 
medicine. 
I think it is my duty to take psychiatric medication 
prescribed for me. 
I would feel guilty if I didn't take psychiatric medication 
prescribed for me. 
Psychiatric medications should be taken if a doctor 
prescribes them. 
I think it would be easy for me to take prescribed 
psychiatric medicine. 
I certainly don't think a patient should feel guilty for 
rejecting prescribed psychiatric medicine. 
Whether you take prescribed psychiatric medicine exactly as 
directed just isn't very important. 
If psychiatric medicine were prescribed for me, I would 
follow the directions carefully. 
I might sample psychiatric medication prescribed for me. 
I feel it would be necessary for me to comply with a 
prescription for psychiatric medication. 
It is easy for me to neglect taking my medication when I 
get busy. 
No matter how busy I get, I always remember to take my 
medication on time. 
Although I have good intentions, it's hard to remember to 
take my medicine regularly. 
Sometimes I can forget my medication when I am too busy. 
10. COGNITIVE EFFICIENCY 
Psychiatric medicine can increase a patient's ability to 
think clearly about his problems. 
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I think prescribed psychiatric medication can help patients 
concentrate better. 
I believe psychiatric medication usually makes thinking 
fuzzy. 
Even though psychiatric medicine might help with emotions, 
it usually makes it harder to think clearly. 
I would not take prescribed psychiatric medicines because 
they would take the edge off my thinking. 
I believe prescribed psychiatric medicines usually would 
make a patient's thinking clearer because of less anxiety. 
Psychiatric medicine might give me the energy to think 
clearly if I were depressed. 
I think it's wrong to take medicine all the time because if 
your thinking is dulled, you don't have a good sense of 
when you're well. 
11. HEALTH BELIEF MODEL DIMENSIONS (Please continue to rate 
items for expression of positive, neutral, or negative 
attitude toward psychiatric medicine.) 
A) GENERAL HEALTH MOTIVATION 
I am very concerned about getting sick. 
The possibility of my getting sick is very low. 
I buy special foods to improve and protect my health. 
I do not take vitamins regularly. 
Compared to other people, I do more things to keep well. 
B) PERCEIVED SUSCEPTIBILITY/SEVERITY 
I tend to be more likely than others to get sick. 
In general, I am less vulnerable to illness than other 
people my age. 
When I do get sick, my illness tends to interfere with my 
daily activities. 
When I become ill, I do not tend to get severely ill. 
I have had much experience with emotional illnesses. 
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C) PROBABILITY THAT COMPLIANT BEHAVIOR WILL REDUCE THREAT 
I believe that psychiatric medication is safe. 
Most psychiatric medicine is not helpful in treating 
emotional problems. 
I generally have faith in doctors and medical care. 
My chances for recovering from emotional illness are poor. 
APPENDIX C 
80-ITEM PMAS 
INFORMED CONSENT 
I, 
as a subject in the research project on Measuring Att~tudes Toward Psvchiatric 
Medicine, conducted under the supervision of Vincent Glaudin, Ph.D., and 
Barbara Stewart, Ph.D. 
I understand that the study involves filling out a questionnaire about my 
attitudes. I understand that possible risks to me associated with this study 
are losing ten minutes of class time. 
It has been eXl)lained to me that the purpose of the study is to learn 
about attitudes toward psychiatric medication, and about how these attitudes 
might affect a person's behavior in treatment. I may not receive any direct 
benefit from participating in this study, but my participation may help to 
increase knowledge which may benefit others in the future. 
Kathryn Paris has offered to answer any questions I may have about the study 
and what is eXl)ected of me in the study. 
I understand that I am free to withdraw from participation in this study at 
any time without jeopardizing either my grade in this class or my relationship 
with Portland State University. 
I have read and understand the foregoing information. 
If you experience problems that are the result of your participation in this 
study, please contact Richard Streeter, Office of Graduate Studies and Research. 
105 Neuberger Hall, Portland State University, 229-3423. 
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PSYCHIATRIC MEDICI~E ATTITUDE SCALE 
I. Demographics 
Please fill in or check the appropriate response: 
Age in years ----- Sex: Male __ _ 
Female __ 
Check the statement that applies to you: 
I have taken prescribed psychiatric medicine in the past but am not 
currently taking it. 
I am currently taking prescribed psychiatric medicine. 
I have never taken prescribed psychiatric medicine. 
II. Instructions 
Circle the letter which best corresponds to the way you feel about each statement. 
Example Strongly Strongly 
Agree Disagree 
The PSU library needs to be open more hours. © b c d e f 
I think that public college tuition should be raised. a b c d e © 
III. Questionnaire Strongly Strongly 
Agree Disagree 
l. In my opinion, any negative side effects are minor 1. a b c d e f 
compared to the good psychiatric medications do. 
2. The best thing about psyc~iatric medicines is that 2. a b c d e f 
they work. 
3. I'm convinced that it isn't natural to reduce 3. a b c d e f 
emotional suffering by using psychiatric 
medication. 
4. I never take my medicine before I think I need it, 4. a b c d e f 
no matter what the written instructions are. 
s. Psychiatric medicines usually cover up problems s. a b c d e f 
that should be faced. 
6. If I didn't like a doctor, I would reject medicine 6. a b c d e f 
he wanted me to take. 
7. I would take prescribed psychiatric medication for 7. a b c d e f 
the sake of my loved ones. 
8. If psychiatric medicine were prescribed for me, 1 8. a b c d e f 
would follow the directions carefully. 
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Strongly 
9. Sven caretully ?rescribed psychiatric medicines 
~re much too risky. 
q. a h 
10. I feel it would be necessary for me to comply 
with a prescription for psychiatric medication. 
10. a b 
11. I would take psychiatric medications prescribed 
by a competent doctor even if he seemed uncaring. 
l l. a b 
12. I don't believe in psychiatric medicines. 12. a b 
13. Psychiatric medications are habit-forming. 
14. I would put up with some uncomfortable medication 
side effects in order to get over a serious 
depression. 
15. I would be relieved to find out that a close 
friend was taking medication for depression. 
13. a 
14. a 
15. a 
16. I believe all psychiatric medicines present a very 16. a 
real danger of addiction. 
17. Whether you take prescribed psychiatric medicine 
exactly as directed just isn't very important. 
18. Psychiatric medicine might give me the energy to 
think clearly if I were depressed. 
17. a 
18. a 
19. I believe people should face their problems without 19. a 
psychiatric medicine. 
20. I think taking psychiatric medicine is a realistic 20. a 
method to lessen discomfort. 
41. une of the best things about most psychiatric 21. a 
medications is that there is no risk of addiction. 
22. Unless friends kept encouraging me to take pre- 22. a 
scribed psychiatric medicine, I would stop. 
23. I would rather have psychological counseling 23. a 
forever than take psychiatric medicines. 
24. I would not take prescribed psychiatric medicines 24. a 
because they take the edge off my thinking. 
25. Psychiatric medicine can increase a patient's 25. a 
ability to think clearly about his problems. 
26. The only value psychiatric medicine has comes from 26. a 
the power of suggestion. 
27. I would never take psychiatric medicine from a 27. a 
doctor I didn't have full confidence in. 
b 
b 
b 
b 
b 
b 
b 
b 
b 
b 
b 
b 
b 
b 
b 
c 
c 
c 
c 
c 
c 
c 
c 
c 
c 
c 
c 
c 
c 
c 
c 
c 
c 
d 
d 
d 
d 
d 
d 
d 
Strongly 
~ Dit11.:.r~t! 
e 
e 
e f 
e f 
e f 
e f 
d e f 
d e f 
d e f 
d e f 
d e f 
d e f 
d e f 
d e f 
d e f 
d e f 
d e f 
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28. I'm afraid that if l took a prescribed psychi-
atric medicine, I would become dependent on it. 
29. Psychiatric medication can help with all kinds 
of problems. 
30. A patient should reject psychiatric medication 
unless every detail is explained carefully. 
Strongly 
..\~ree 
:!8. a b 
29. a b 
30. a b 
31. I think it's wrong to take medicine all the time 31. a 
because if your thinking is dulled, you don't have 
b 
a good sense of when you're well. 
32. I could take prescribed psychiatric medicines 32. a b 
without becoming dependent on them. 
33. Having to take psychiatric medicines is no way 33. a b 
to live. 
34. I think psychiatric medicines usually have bad 34. a b 
side effects. 
35. Once I had the medical facts carefully explained 35. a b 
to me, I would take necessary psychiatric medi-
cation. 
36. I think some problems can be faced up to better 36. a b 
with the support of psychiatric medications. 
37. I would not take prescribed psychiatric medi- 37. a b 
cation even if every detail were explained to me. 
38. The trouble with psychiatric medicines is that 38. a b 
they just don't work. 
39. Having the scientific information would in- 39. a b 
fluence me to take psychiatric medication 
prescribed for me. 
40. I would take psychiatric medication prescribed 40. a b 
for me because I believe it is pretty effective. 
41. Carefully prescribed psychiatric medicines have 41. a b 
no danger of addiction. 
42. If my family seemed uninterested in my treatment, 42. a b 
I would throw prescribed psychiatric medicine down 
the sink. 
43. No matter how busy t get, I always remember to 43. a b 
take my medication on.time. 
44. I would not take psychiatric medication prescribed 44. a b 
to me if my family and friends seemed very 
interested. 
45. I believe psychiatric medication usually makes 45. a b 
thinking fuzzy. 
c d 
c d e 
c d 
c d e 
c d e 
c d e 
c d e 
c d e 
Strong l ~; 
Di~agre~ 
f 
f 
f 
f 
f 
f 
c d e f 
c d e f 
c d e f 
c d e f 
c d e f 
c d e f 
c d e f 
c d e f 
c d e f 
c d e f 
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46. Psychiatric medication can help provioe the 
energy to face overwhelming problems. 
47. I would be hesitant to take psychiatric medica-
tion prescribed for me without knowing all 
about it. 
48. When I have emotional problems, I want psychiat-
ric medicine prescribed for me. 
49. Host prescribed psychiatric medicines are safe 
to take over a period of months. 
50. I don't care how safe a psychiatric medication 
is reported to be, I still wouldn't take it. 
51. I would not take medicine from a doctor who was 
disrespectful. 
Strongly 
Agree 
46. ·'3. b 
47. a b 
48. a. b 
49. a b 
50. a b 
51. a b 
c d 
c d 
c d 
c d 
c d 
c d 
e 
e 
e 
e 
e 
Str:)n.~i:· 
Ll is.::i~r1.~-= 
f 
f 
f 
f 
32. I think prescribed psychiatric medication can 52. a b c d e f 
help patients concentrate better. 
53. I take my medication regularly regardless of 53. a b c d e f 
what my family thinks of it. 
54. I believe psychiatric medicines basically poison 54. a b c d e f 
the body. 
SS. It is easy for me to neglect taking my medication SS. a b c d e f 
when I get busy. 
56. I would take psychiatric medicine prescribed for 56. a b c d e f 
me and not worry about scientific details. 
57. Psychiatric medicine is only an emotional crutch. 57. a b c d e f 
58. Psychiatric medicines are too weak to help treat 58. a b c d e f 
big problems. 
59. If the doctor explains what effects the medicine 59. a b c d e f 
might have on me, I would take it as prescribed. 
60. I would take psychiatric medication I needed 60. a b c d e f 
whether I liked the doctor or not. 
61. I think it's always best to seek medical help for 61. a b c d e f 
severe depression. 
62. It would be impossible for me to take psychiatric 62. a b c d e f 
medicine from a doctor I didn't trust. 
63. I see psychiatric medicine as a last resort to 63. a b c d e f 
coping with emotional problems. 
64. You can't expect a patient to take psychiatric 64. a b c d e g 
medication if no one cares. 
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Strongly 
Agree 
65. Psvchiatric medicines which are prescribed by 65. a b 
a doctor have been carefully screened by 
scientific studies. 
66. Frequently, patients can learn new ways of coping 66. a 
because psychiatric medicines break up old anxiety 
patterns. 
b 
67. Even though psychiatric medicine might help with 
emotions, it usually makes it harder to think 
clearly. 
68. I have no qualms about trying psychiatric medica-
tion my doctor recommends. 
69. I think a patient should take prescribed psychi-
atric medicine even if family and friends don't 
understand. 
67. a 
68. a 
69. a 
b 
b 
b 
70. I think psychiatric medications almost always 70. a b 
block you from having feelings you should 
experience. 
71. I think it is my duty to take psychiatric medi- 71. a b 
cation prescribed for me. 
72. I'll try whatever psychiatric medicine my doctor 72. a b 
recommends. 
73. Once you begin taking psychiatric medicine, it is 73. a b 
hard to give it up. 
74. I believe prescribed psychiatric medicines usually 74. a b 
would make a patient's thinking clearer because 
of less anxiety. 
75. All the medical informa~ion in the world couldn't 75. a b 
convince me to take psychiatric medication. 
76. It would be easy for me to forget to take my 
medication. 
77. I believe psychiatric medications can make it 
possible to learn new behavior in frightening 
situations. 
78. The risk of suicide is much greater than any 
risk in prescribed psychiatric medications. 
79. Being more relaxed is something you can count on 
from taking psychiatric medicines. 
80. Other people's opinions would never stop me from 
taking the medication ! need. 
76. a b 
77. a b 
78. a b 
79. a b 
80. a b 
c d 
c d 
c d 
c d 
c d 
c d 
c d 
c d 
c d 
c d 
c d 
c d 
c d 
c d 
c d 
c d 
e 
e 
e 
e 
e 
e 
e 
e 
e 
e 
e 
e 
e 
e 
e 
e 
Strongly 
Disagree 
f 
f 
f 
f 
f 
f 
f 
f 
f 
f 
f 
f 
f 
f 
f 
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APPENDIX D 
PSYCHIATRIC MEDICINE ATTITUDE SCALE 
PSYCHIATRIC MEDICINE ATTITUDE SCALE A 
NAME. _____________________________________________ DATE ________________ __ 
Age __ Sex_ Years of education completed ___ Oc:c:upation ______________ _ 
Check al I the statements that apply to you: 
- I have never taken prescribed psychiatric medicine. 
- I have taken prescribed psychiatric: medicine in the past. 
INSTRUCTIONS 
I am currently taking prescribed psychiatric medici~e. 
I am considering starting to take psychiatric medicine. 
A person I know well (relative, friend) is currently taking or 
has taken prescribed psychiatric medicine. 
.9!s!!. the letter which best corresponds to the way you feel about each statement. 
EXAMPLE Strongly ~ ~ Agree 
1 • The streets where I live are adequately paved. 1. a b c: d 
2. My neighbors are friendly. 2. a @ c: d 
QUESTIONNAIRE Strof9y ~ 
1. Psychiatric !MdlciM can help prowide the ......,, to face ov.rwheimi"9 prabl.,.. 1. 0 b c: 
2. I think pl)IChiotrlc !lllldlcU.._ uually have -.. 1ide effects. 2. 0 b c: 
3. I would talut fl'YChlalric !lllldlcation ..-a.. far ,. ~ I believe it ia pretty effective. 3. 0 b c: 
... It is easy for me to neelec:t taking my !lllldication wMrl I 99f buay. 
"'· 
0 b c: 
5. I be4ieve pl)IChiotPic medicatione con molce it po11ible to 1.-n new behavior in ffight9nift9 situotionl. 5. Q b c 
6. The trouble with peyc:hiotric mediciMI i1 thot they just don't woril. 6. Q b c 
7. I would take pa)IChiotric: medicine preKribed for me and nat worry about scientific details. 7. Q b c 
8. Even carefully preteribed pa~hlatric medici,.. ore much toa risky. 8. Q b c 
9. Once I head the mediccd factl cCll'ltfully ..Pained to me, I would lake nee......, peyc:hiatric medication. 9. Q b c 
10. I doti't believe in pl)IChiotPic medlcinea. 10. 0 b c 
11. I believe pretCribed paychlatric medlclMS uudly would make a potl•t11 thinking cl..., becou• 
of •- anxiety. 11. Q b c 
12. I would put up with IOll'le '-riCCIAfoituble medication 11• effects in Ofder to ;et ovw o aerioul ..... ion. 12. a b c 
13. Even thou9h pi11Chiotric Ndlcine might help with efll0tion1, it U1UC1lly rnalcel It harder to think c:l ... ly. 13. Q b c 
1-4. I thi'* a patient ..,Id take ...-:ribed peychiotPlc medlci .. even if family and frl..- doti't undentand. 1-4. Q b c 
15. Once you betin laking paychicnric medJciM, it ii t.d to give It up. 15. a b c 
16. I have no ~"" about trying paychiotPlc Ndlcotlon my cb:tor recoi1-.lda. 16. a b c 
17. I would be retl.ved to find a..t that o c:I01e friend W9 "*lft9 lhlldlcotlon for .,_.ion. 17. Q b c 
18. I would not take sw-cribed Pl)'Chiotric: Ndlc:atlon even If every detail wwe exploined to me. 18. Q b c: 
19. Whe~ you take pNICribed paychiotrlc medicine uoctly as directed juat i1n't very importQnt. 19. a b 
20. I would take prescribed pt)IChiatric medication for the taile of my loved onea. 20. Q b c 
Strongly 
Oi10gree 
e (!) 
• f 
Sh'ongly 
01..-
d • 
d • 
d • 
d e 
d • 
d • 
d • 
d • 
d • 
d • 
d • 
d e 
d e 
d e 
d • 
d • 
d • 
d • 
d • 
d • 
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PSYCHIATRIC MEDICINE ATTITUDE SCALE 8 
NAME DATE:.---------:-----------------------------------------
Age_ Sex __ Yean of education completed ___ Occupation. ______________ _ 
Check all the statements that apply to you: 
- I have never tak.n presc:ribed psychiatric medicine. 
- I have taken prescribed psychiatric medicirte in the past. 
INSTRUCTIONS 
I om currently taking prescribed psychiatric medicine. 
I am considering starting to take psychiatric medicine. 
A person I know wel I (relative, friend) is currently taking or 
has taken prescribed psychiatric medicine. 
~ the letter which best corresponds to the way you feel about eoch statement. 
EXAMPLE Strongjy ~ ~ Agree 
1. The streets where I live are adequately paved. 1. a b c d 
2. My neighbors are friendly. 2. a @ c d 
QUESTIONNAIRE Slrongfy 
A.-
l ~ I thi,. hlki"I p1ychiotric medicine la a realistic method to 1-.n dllCCllllfort. I. 0 b c 
2. I beileve ~hiotric medication UIUGlly ...... thinkl"I fuzzy. 2. a b c 
3. Hcwi"I the tcientlflc il1ionnotlon wouAd influence nie to hike paychlotrlc medication pNeCribecUar me .. 3. 0 b c 
•• Psychiatric medici,... 111uaUy cover up pnibl ... that should be faced. •• 0 b c 
s. I 'II try wtlatw¥er Pl)'Chlotric medicine my doctor l'9COlllnl9ndl. 5. 0 b c 
6. I don't care how IOfe a p1ychiatric medication i1 r.,orted to be, I still wouldn't take it. 6. Q b c 
7. One of the belt things about moat p1ychiotric mec:lication i1 that there i1 no ritk of addiction. 7. Q b c 
8. All the medical information in the world coul•'t convince me to take paychiotrlc medication. 8. Q b c 
9. If the doctor explolN what eH.ctl the medicine might hcwe on me, I would take it 01 preecribed. 9. Q b c 
10. I thi .. paychlatrlc mecllcatlona ollllOlt alwaya black you ffOlft hcwi"I f•lift91 you anauld experience. 10. 0 b c 
11. I tolce my medication regulariy regard&- of what my family thl• of It. 11. Q b c 
12. I wauld rather hcwe Pl)'ChoAQ9icai cou...tl"I ro.-. ttw. take fllYChiotrlc medlci,.. 12. Q b c 
13. 1 'm afraid that if I toaA& a pr..:rlbed ~hlatric medicine, I would becanw .,.,...,. on it. 13. 0 b c 
14. Psychiatric medicine ntitht gi.,. me the ..... to think clearfy if l were .,._... 14. a b c 
15. Psychiatric medlcottor. ore habit-fanning. 15. 0 b c 
16. I would ~ p1ychlotric: medication l needed wmttw l I lked tt. cmctar or not. 16. 0 b c 
17. I thl,. .,... proDI ... can be faced up to better with the IUflPO"' of plydtlatrlc medlcatlona. 17. a b c 
18. F,..,.mty, potientl con learn new waya of copt"I-... fllYChiatrlc medlclnea bNak 
up old anxiety pottwna. 
18. 0 b c 
'9.1 would be helin.tt to tab p1ychiotrlc medication pr..:ribed for me without kr»Wlnt oll about it. 19. Q b c 
20. I think pr..:ribed paychiatric medication can hefp patientl concetttroN better. 20. Q b c 
Strongly 
Disagree 
• (!) 
e f 
S"°""y 
DilG9"" 
d • f 
d • 
d • 
d • 
d • 
d • 
d • 
d • 
d • 
d • 
d • 
d • 
d • 
d e 
d • 
d • 
d • 
d • 
d • 
d • 
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